Related Experiment Video
Updated: Jul 16, 2025

Author Spotlight: Insights into the Techniques and Findings of Recent Advancements in Epilepsy Research
Published on: October 13, 2023
Electrophysiological characterization of a Cav3.2 calcium channel missense variant associated with epilepsy and
Robin N Stringer1,2, Leos Cmarko2,3,4, Gerald W Zamponi5
1Department of Pathophysiology, Third Faculty of Medicine, Charles University, Prague, Czech Republic.
Abstract:
T-type calcium channelopathies encompass a group of human disorders either caused or exacerbated by mutations in the genes encoding different T-type calcium channels. Recently, a new heterozygous missense mutation in the CACNA1H gene that encodes the Cav3.2 T-type calcium channel was reported in a patient presenting with epilepsy and hearing loss-apparently the first CACNA1H mutation to be associated with a sensorineural hearing condition. This mutation leads to the substitution of an arginine at position 132 with a histidine (R132H) in the proximal extracellular end of the second transmembrane helix of Cav3.2. In this study, we report the electrophysiological characterization of this new variant using whole-cell patch clamp recordings in tsA-201 cells. Our data reveal minor gating alterations of the channel evidenced by a mild increase of the T-type current density and slower recovery from inactivation, as well as an enhanced sensitivity of the channel to external pH change. To what extend these biophysical changes and pH sensitivity alterations induced by the R132H mutation contribute to the observed pathogenicity remains an open question that will necessitate the analysis of additional CACNA1H variants associated with the same pathologies.
Insights
A CACNA1H gene mutation (R132H) linked to epilepsy and hearing loss shows minor T-type calcium channel gating changes. Further research is needed to understand how these biophysical alterations contribute to the disorder.
Area of Science:
- Neuroscience
- Genetics
- Biophysics
Background:
- T-type calcium channelopathies are human disorders linked to mutations in T-type calcium channel genes.
- A novel CACNA1H gene mutation (R132H) was recently identified in a patient with epilepsy and sensorineural hearing loss.
Observation:
- The R132H mutation affects the Cav3.2 T-type calcium channel, located in the second transmembrane helix.
- Electrophysiological characterization was performed using whole-cell patch clamp recordings in tsA-201 cells.
Findings:
- The R132H mutation caused minor alterations in channel gating, including increased T-type current density and slower recovery from inactivation.
- The mutated Cav3.2 channel exhibited enhanced sensitivity to external pH changes.
Implications:
- The precise contribution of these biophysical changes and altered pH sensitivity to the observed pathogenicity requires further investigation.
- Analyzing additional CACNA1H variants associated with similar pathologies is crucial for a comprehensive understanding.
Related Concept Videos
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...

